High‐dose chemotherapy for relapsed germ cell tumours: outcomes in low‐volume specialized centres

Author:

Connolly Elizabeth A.12ORCID,Weickhardt Andrew345,Grimison Peter125ORCID,Asher Rebecca6,Heller Gillian Z.26,Lewin Jeremy75ORCID,Liow Elizabeth78,Toner Guy75,Tung Iris L.Y.7,Tran Ben785,Hill Sean9,Walpole Euan9,McKenzie Jane3,Kuchel Anna10,Goh Jeffrey10,Forgeson Garry11,Tan Alvin12,Joshi Abhishek13,Wickham Alistair14,Tan Hsiang15,Wang Yang16,Winstanley Mark A.17,Hamad Nada181920,Wong Vanessa34

Affiliation:

1. Chris O Brien Lifehouse SydneyAustralia

2. University of Sydney SydneyAustralia

3. Olivia Newton‐John Cancer and Wellness Centre Austin Health MelbourneAustralia

4. Walter and Eliza Hall Institute of Medical Research MelbourneAustralia

5. Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)

6. NHMRC Clinical Trials Centre, Sydney Sydney Australia

7. Peter MacCallum Cancer Centre MelbourneAustralia

8. Royal Melbourne Hospital MelbourneAustralia

9. Princess Alexandra Hospital BrisbaneAustralia

10. Royal Brisbane and Women's Hospital and School of Medicine University of Queensland BrisbaneAustralia

11. Palmerston North Hospital Palmerston NorthNew Zealand

12. Waikato Hospital Hamilton New Zealand

13. Townsville University Hospital James Cook University TownsvilleAustralia

14. Auckland City Hospital Auckland New Zealand

15. Royal Adelaide Hospital AdelaideAustralia

16. St Vincent's Hospital Melbourne Australia

17. Starship Children's Hospital Auckland New Zealand

18. Australasian Bone Marrow Transplant Recipient Registry (ABMTRR) Sydney Australia

19. St Vincent's Hospital Sydney SydneyAustralia

20. University of New South Wales Sydney Australia

Publisher

Wiley

Subject

Urology

Reference28 articles.

1. Testicular Cancer — Discoveries and Updates

2. Management of poor-prognosis or relapsed germ-cell cancer

3. National Comprehensive Cancer Network.Testicular Cancer Version 1.2021. NCCN Clinical Practice Guidelines in Oncology. Accessed February 25 2021. Available from:https://www.nccn.org/professionals/physician_gls/pdf/testicular.pdf

4. Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

5. Salvage treatment for testicular cancer with standard- or high-dose chemotherapy: a systematic review of 59 studies

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3